Cargando…
Immunomodulation of Mesenchymal Stem Cells in Acute Lung Injury: From Preclinical Animal Models to Treatment of Severe COVID-19
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a major public health challenge worldwide. Owing to the emergence of novel viral variants, the risks of reinfections and vaccine breakthrough infections has increased co...
Autores principales: | Li, Ju-Pi, Wu, Kang-Hsi, Chao, Wan-Ru, Lee, Yi-Ju, Yang, Shun-Fa, Chao, Yu-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331939/ https://www.ncbi.nlm.nih.gov/pubmed/35897770 http://dx.doi.org/10.3390/ijms23158196 |
Ejemplares similares
-
Immunomodulation via MyD88-NFκB Signaling Pathway from Human Umbilical Cord-Derived Mesenchymal Stem Cells in Acute Lung Injury
por: Wu, Kang-Hsi, et al.
Publicado: (2022) -
Alterations of mesenchymal stem cells on regulating Th17 and Treg differentiation in severe aplastic anemia
por: Li, Ju-Pi, et al.
Publicado: (2023) -
Mesenchymal Stem Cells in Acquired Aplastic Anemia: The Spectrum from Basic to Clinical Utility
por: Wang, Xing-An, et al.
Publicado: (2023) -
Ling Zhi-8, a fungal immunomodulatory protein in Ganoderma lucidum, alleviates CPT-11-induced intestinal injury via restoring claudin-1 expression
por: Li, Ju-Pi, et al.
Publicado: (2023) -
Mesenchymal Stem Cells as Immunomodulators in a Vascularized Composite Allotransplantation
por: Kuo, Yur-Ren, et al.
Publicado: (2012)